Je was op zoek naar: neovaskularisation (Deens - Engels)

klassisk subfoveal choroidal neovaskularisation (cnv), eller
classic subfoveal choroidal neovascularisation (cnv) or

våd amd karakteriseres af patologisk koroidal neovaskularisation (cnv).
wet amd is characterised by pathological choroidal neovascularisation (cnv).

- patienter med subfoveal choroidal neovaskularisation sekundært til patologisk myopi.
- patients with subfoveal choroidal neovascularisation secondary to pathological myopia.

for stor aktivering af disse receptorer af vegf-a kan resultere i patologisk neovaskularisation og for stor vaskulær permeabilitet.
excessive activation of these receptors by vegf-a can result in pathological neovascularisation and excessive vascular permeability.

formålet var at vise langtidseffekt og sikkerhed af fotodynamisk behandling med verteporfin med hensyn til begrænsning i synstab hos patienter med subfoveal choroidal neovaskularisation på grund af aldersrelateret makuladegeneration.
the objective was to demonstrate the long-term efficacy and safety of photodynamic therapy with verteporfin in limiting the decrease in visual acuity in patients with subfoveal choroidal neovascularisation due to age-related macular degeneration.

fordelen ved at give lægemidlet til personer med aldersrelateret makuladegeneration (amd) med okkult subfoveal choroidal neovaskularisation med dokumenteret nylig eller pågående sygdomsforværring er ikke blevet tydeligt påvist.
the benefit of the product in the amd patient population who have occult subfoveal cnv with evidence of recent or ongoing disease progression has not been demonstrated consistently.

aldersrelateret makuladegeneration med okkult læsion uden klassisk komponent fordelen ved at give produktet til personer med aldersrelateret makuladegeneration (amd) med okkult subfoveal choroidal neovaskularisation med dokumenteret nylig eller pågående sygdomsforværring er ikke blevet tydeligt påvist.
age-related macular degeneration with occult with no classic lesions the benefit of the product in the amd patient population who have occult subfoveal cnv with evidence of recent or ongoing disease progression has not been demonstrated consistently.

i forsøg fvf2598g (marina) fik patienter med minimalt klassisk cnv eller okkult og ingen klassisk choroidal neovaskularisation (cnv) månedlige intravitreale injektioner af lucentis 0, 3 mg eller 0, 5 mg eller simuleret injektioner.
in study fvf2598g (marina), patients with minimally classic or occult with no classic choroidal neovascularisation (cnv) received monthly intravitreal injections of lucentis 0.3 mg or 0.5 mg or sham injections.